97069-9
History of Coagulation disorder AndOr blood-thinning medication use
Active
LOINC Names Get Info
- Fully-Specified Name
- Coagulation disorder &or blood-thinning medication use:
Hx: Pt: ^Patient: Ord: - Long Common Name
- History of Coagulation disorder AndOr blood-thinning medication use
- Short Name
- Hx coag disorder &/or bld-thin med
Part Model Get Info
- Component
- Coagulation disorder &or blood-thinning medication use
LP426316-8
- Analyte
- Coagulation disorder &or blood-thinning medication use
LP426316-8
- Component Numerator
- Coagulation disorder &or blood-thinning medication use
LP426316-8
- Component Numerator Core
- Coagulation disorder &or blood-thinning medication use
LP426316-8
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Hx
LP6817-3
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- Ord
LP7751-3
- Method
- NULL
Example Answer List: LL361-7
Source: Regenstrief Institute| Answer | Code | Score | Answer ID |
|---|---|---|---|
| YesCopyright http://snomed.info/sct ID:373066001 Yes (qualifier value) | LA33-6 | ||
| NoCopyright http://snomed.info/sct ID:373067005 No (qualifier value) | LA32-8 |
Basic Attributes
- Class
- H&P.HX
- Type
- Clinical
- First Released
- Version 2.70
- Last Updated
- Version 2.70 (ADD)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name | Answer List | Answer List Type | Answers |
|---|---|---|---|---|
| 97065-7 | Medical history for preventive vaccination against COVID-19 (Coronavirus Disease 2019) - with mRNA vaccine | LL361-7 | Normative | 2 |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Διαταραχή πήξης και/ή χρήση αντιπηκτικής φαρμακευτικής αγωγής: Synonyms: - H& |
| es-MX | Spanish (Mexico) | Trastorno de la coagulación o uso de medicamentos anticoagulantes: |
| it-IT | Italian (Italy) | Disturbo della coagulazione &o uso di farmaci che fluidificano il sangue: Synonyms: Anamnesi Disturbo della coagulazione e/o uso di farmaci che fluidificano il sangue paziente Punto nel tempo (episodio) |
| pl-PL | Polish (Poland) | Krzepnięcie zaburzenia & lub stosowanie leków rozrzedzających krew: Synonyms: Zaburzenia Krzepnięcia i/oraz stosowanie leków rozrzedzających krew |
| zh-CN | Chinese (China) | 凝血功能障碍和/或使用血液稀释剂: Synonyms: 依次型; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://